glp-1 and eye issues Drugs Ocular Disease: Between Neuroprotection and Risk Taking GLP-1 medications? Don't forget

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas

Funding This work was supported by grant 81872388 from the National Natural Science Foundation of China and grant 2018SCUH0009 from the Fundamental Research Fund for the Central Universities

No prior authorization, insurance claims, or employer documentation is required

Journal of Psychiatric Research

The increase in UA following uricase knockout resulted in attenuation of behavioural and neurochemical pathology, while animals overexpressing this gene showed an enhancement of these measures